Old Web
English
Sign In
Acemap
>
authorDetail
>
May-Lin Helen Oh
May-Lin Helen Oh
Changi General Hospital
Dengue vaccine
Medicine
Immunology
Dengue fever
Neutralizing antibody
3
Papers
84
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Humoral and cellular immunogenicity and safety following a booster dose of a tetravalent dengue vaccine 5+ years after completion of the primary series in Singapore: 2-year follow-up of a randomized phase II, placebo-controlled trial.
2021
Human Vaccines & Immunotherapeutics
Juliana Park
Sophia Archuleta
May-Lin Helen Oh
Lynette Pei-Chi Shek
Wang Hao
Matthew Bonaparte
Carina Frago
Alain Bouckenooghe
Frédérique Jantet-Blaudez
Sarah Begue
Sophie Gimenez-Fourage
Anke Pagnon
Show All
Source
Cite
Save
Citations (0)
Immunogenicity and safety of a dengue vaccine given as a booster in Singapore: a randomized Phase II, placebo-controlled trial evaluating its effects 5–6 years after completion of the primary series
2019
Human Vaccines & Immunotherapeutics
Juliana Park
Sophia Archuleta
May-Lin Helen Oh
Lynette Pei-Chi Shek
Jing Jin
Matthew Bonaparte
Carina Fargo
Alain Bouckenooghe
Show All
Source
Cite
Save
Citations (3)
Immunogenicity and safety of recombinant tetravalent dengue vaccine (CYD-TDV) in individuals aged 2-45 years Phase II randomized controlled trial in Singapore
2012
Human Vaccines & Immunotherapeutics
Yee Sin Leo
Annelies Wilder-Smith
Sophia Archuleta
Lynette Pei-Chi Shek
Chia Yin Chong
Hoe Nam Leong
Chian-Yong Low
May-Lin Helen Oh
Alain Bouckenooghe
T. Anh Wartel
Denis Crevat
Show All
Source
Cite
Save
Citations (81)
1